Search Results 161-170 of 11347 for ���������������������������:za33���24������ ������������������������ ������

  1. Tattoo removal - Mayo Clinic

    Accessed Jan. 24, 2018. Unwanted tattoos. American Society for Dermatologic Surgery. https://www.asds.net/_PublicResources.aspx?id=898&terms=tattoo. Accessed ...

  2. Clinical trials - Oncology (Medical)

    The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 24 months of HLA-A LOH status; Percentage of screened ...

  3. Cosmetic Center in Arizona - Clinical trials

    24, 2022. Share on: FacebookTwitter. Cosmetic Center in Arizona. Sections. Request an appointment · Overview · Cosmetic services · Cosmetic regenerative ...

  4. Clinical trials - Oncology (Medical)

    The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...

  5. Publications

    2019 Oct; 24 (5):442-451 Epub 2019 July 27. View PubMed; Misra S, Shishehbor MH, Takahashi EA, Aronow HD, Brewster LP, Bunte MC, Kim ESH, Lindner JR, Rich K ...

  6. A Study to Evaluate Intravenous Erenumab in Patients with Status Migrainosus - Mayo Clinic

    ... 24 hours, and to evaluate late endpoints of response including change in migraine days at 4 weeks compared to baseline report, change in headache days at 4 ...

  7. Clinical trials - Oncology (Medical)

    Giving a shorter hormone therapy treatment may work the same at controlling prostate cancer compared to the usual 24 month hormone therapy treatment in patients ...

  8. Gastroenterology and Hepatology - Clinical trials

    ... 24; Month 6) Visit 9 (Week 52; Month 12). Visit 10 (Week 104, Month 24). Study to Evaluate Efficacy, Safety and Tolerability of HM15211 in Subjects. Rochester ...

  9. Prostate Cancer Cell Lines Using Biopsies of Early Stage Prostate Cancer Patients and Research on Cancer Mechanisms Through Its Genes and Proteins - Mayo Clinic

    Overview. Tab Title Description. Study IDs. Study IDs. Site IRB. Rochester, Minnesota: 24-006965. Sponsor Protocol Number: 24-006965. About this study. The ...

  10. Clinical trials - Oncology (Medical)

    The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...